Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer
Asthma Attacks Asthma attacks are more likely when using an inhaled form of glutathione, not glutathione IV therapy
The physiological landscape of Long COVID, ME/CFS, and related dysautonomias is heavily characterized by a profound, unyielding state of oxidative stress
Most side effects are mild and tend to resolve as your body adjusts
The most commonly reported early changes: Improved baseline energy: less reliance on caffeine or stimulants to maintain daytime energy levels Better exercise recovery: faster resolution of muscle soreness, less multi-day fatigue after hard training Improved mental stamina: sustained focus and cognitive performance over longer periods Better sleep quality: improved mitochondrial energy availability supports the overnight repair and restoration processes that determine sleep quality Reduced fatigue severity: patients with significant baseline fatigue often notice the most meaningful changes in this window Long-Term: Months 3+ and Ongoing The full benefit profile of SS-31 develops and compounds over 3 to 6 months of consistent use
Glycine combinations, as discussed in our semaglutide with glycine and tirzepatide glycine guides, may actually support gut health during the adjustment period
